Cargando…

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

Atherosclerosis is a chronic inflammatory vascular disease driven by traditional and nontraditional risk factors. Genome-wide association combined with clonal lineage tracing and clinical trials have demonstrated that innate and adaptive immune responses can promote or quell atherosclerosis. Several...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Peng, Cui, Zi-Yang, Huang, Xiao-Fu, Zhang, Dan-Dan, Guo, Rui-Juan, Han, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033871/ https://www.ncbi.nlm.nih.gov/pubmed/35459215 http://dx.doi.org/10.1038/s41392-022-00955-7

Ejemplares similares

Emerging Piezo1 signaling in inflammation and atherosclerosis; a potential therapeutic target
por: Shinge, Shafiu A. Umar, et al.
Publicado: (2022)

NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
por: Lu, Na, et al.
Publicado: (2022)

Inflammation as a Therapeutic Target in Atherosclerosis
por: Nguyen, Mau T, et al.
Publicado: (2019)

Signaling pathways and therapeutic interventions in gastric cancer
por: Lei, Zi-Ning, et al.
Publicado: (2022)

Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021)

The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis
por: Mahdavi Gorabi, Armita, et al.
Publicado: (2019)

Inflammation and aging: signaling pathways and intervention therapies
por: Li, Xia, et al.
Publicado: (2023)

A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease
por: Gao, Ya-Kun, et al.
Publicado: (2022)

Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis
por: Zhang, Dan-Dan, et al.
Publicado: (2021)

Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation
por: Luo, Yonghong, et al.
Publicado: (2021)

Correction: Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis
por: Zhang, Dan-Dan, et al.
Publicado: (2021)

Signaling pathways in obesity: mechanisms and therapeutic interventions
por: Wen, Xue, et al.
Publicado: (2022)

Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
por: Li, Bin, et al.
Publicado: (2017)

Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
por: Karunakaran, Denuja, et al.
Publicado: (2016)

Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits
por: Huang, Ying, et al.
Publicado: (2018)

Annexin A1 involved in the regulation of inflammation and cell signaling pathways
por: Han, Peng-Fei, et al.
Publicado: (2020)

The Molecular Pathways of Pyroptosis in Atherosclerosis
por: Song, Dan, et al.
Publicado: (2022)

Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages
por: Xi, Dan, et al.
Publicado: (2018)

Correction To: Signaling pathways in obesity: mechanisms and therapeutic interventions
por: Wen, Xue, et al.
Publicado: (2022)

Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential
por: Márquez, Andrea Bonnin, et al.
Publicado: (2021)

Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
por: Engelen, Suzanne E., et al.
Publicado: (2022)

Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis
por: Liao, Minqi, et al.
Publicado: (2021)

PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway
por: Liu, Zhenzhu, et al.
Publicado: (2021)

Inflammation and Atherosclerosis
por: Ley, Klaus
Publicado: (2021)

Heterozygous SOD2 deletion deteriorated chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through mtROS-NLRP3 signaling pathway
por: Song, Jie-qiong, et al.
Publicado: (2020)

TIPE2 suppresses atherosclerosis by exerting a protective effect on macrophages via the inhibition of the Akt signaling pathway
por: Li, Dan, et al.
Publicado: (2019)

The emerging role of pyroptosis-related inflammasome pathway in atherosclerosis
por: Xu, Xiao-Dan, et al.
Publicado: (2022)

Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway
por: Bao, Ruixia, et al.
Publicado: (2022)

Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
por: Dong-Chen, Xu, et al.
Publicado: (2023)

RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment
por: Kong, Peng, et al.
Publicado: (2023)

Signaling pathways in brain tumors and therapeutic interventions
por: Li, Shenglan, et al.
Publicado: (2023)

Inflammation and tumor progression: signaling pathways and targeted intervention
por: Zhao, Huakan, et al.
Publicado: (2021)

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020)

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019)

Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis
por: Qiao, Lei, et al.
Publicado: (2021)

Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis
por: Chen, Pei-Yu, et al.
Publicado: (2019)

Apocynum Leaf Extract Suppresses the Progress of Atherosclerosis in Rats via the FKN/SYK/p38 Signal Pathway
por: Zhang, Dan, et al.
Publicado: (2021)

Epigenetics in atherosclerosis and inflammation
por: Wierda, Rutger J, et al.
Publicado: (2010)

Inflammation and autoimmunity in atherosclerosis
por: Surma, Stanislaw, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k8v5drfisg2qfmha2q517ohfv4